Current stock page

Catalysts

LLY Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareDrug Manufacturers - GeneralScore data as of Sep 2, 2026

LLY

Catalysts
Eli Lilly and Company
Healthcare· Drug Manufacturers - General
AIQ Score
NeutralAIQ Edge 3/10
Low Priority
Relative Laggard
Score data as of Sep 2, 2026
Last price
$1,165.59
+$5.59 (+0.48%)
Latest market quote
Momentum23
Value25
Quality76
Risk Resilience45
Sentiment
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Oct 29, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 43/100

Momentum 23/100 and sentiment before the next covered event.

Recent coverage
2 articles

Updated Sep 2, 2026 · Sentiment 32.64%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 23/100AIQ Edge 3/10 Relative Laggard
Beat rate
88%
7 of 8 reported periods
Average surprise
+10.9%
Across covered historical reports
Latest result
+30.9%
Aug 5, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Aug 5, 2026$6.40$8.38+30.9%$20.82B$22.97B
Apr 30, 2026$6.97$8.55+22.7%$17.82B$19.8B
Feb 4, 2026$6.91$7.54+9.1%$17.94B$19.29B
Oct 30, 2025$5.69$7.02+23.4%$16.05B$17.6B
Aug 7, 2025$5.60$6.31+12.7%$14.7B$15.56B
May 1, 2025$3.26$3.34+2.5%$12.67B$12.73B
Feb 6, 2025$5.03$5.32+5.8%$13.53B
Oct 30, 2024$1.47$1.18-19.7%$12.1B$11.44B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
24
Buy
4
Hold
2
Sell
12-month analyst target
$1,331.12
+14.20% versus current price
Based on 16 analyst observations. Targets are estimates, not predictions.
Low target
$1,119.00
-4.00% vs latest price
Average target
$1,331.12
+14.20% vs latest price
High target
$1,500.00
+28.69% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateOct 29, 2026

Next known earnings or reporting date.

EPS estimate$9.85

Current analyst expectation for the upcoming report.

Revenue estimate$22.16B

Current analyst expectation for the upcoming report.

Sentiment score

News pressure around the setup.

Momentum score23

Where event reaction would show up first.

AIQ score43/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
16
Average target
$1,331.12
Target upside
14.20%
Target range
$1,119.00 - $1,500.00
90-day revisions
10

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
2
Neutral
0
Negative
0
insidermonkey.com · Aug 31, 2026

Eli Lilly (LLY) Makes a $2.88 Billion Autoimmune Bet. What Could Go Right or Wrong?

Eli Lilly and Company (NYSE:LLY) has agreed to acquire privately held Merida Biosciences for up to $2.875 billion in cash, including an upfront payment and milestone-based payments.

gurufocus.com · Aug 31, 2026

LLY Looks 24.4% Undervalued on GF Value™ Amid Obesity Treatment Market Surge

On August 31, 2026, the obesity treatment sector is witnessing accelerated competition as oral GLP-1 formulations gain market traction faster than anticipated.

Open full news and sentiment

LLY Catalysts FAQ

What are the next catalysts for LLY stock?

LLY's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move LLY stock?

Upcoming events that could move LLY include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could LLY's next earnings report affect the stock?

LLY's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive LLY stock higher?

LLY could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt LLY stock?

LLY could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.

How could Mounjaro and Zepbound growth affect LLY stock?

Mounjaro and Zepbound can affect LLY through revenue growth, margins, capacity, competitive share, and investor expectations. Use this catalyst page to connect upcoming obesity-drug updates with earnings, analyst targets, and AIQ momentum.